When does the Xarelto (rivaroxaban) patent end?
“Xarelto patent end” depends on which protection you mean—US patents, other countries, and whether you’re asking about the last patent in the supply chain or the earliest date generics/biosimilars can launch. The exact end date therefore varies by patent and jurisdiction, and multiple patents can extend exclusivity beyond a single “end date.”
How do I find the exact patent-expiration date for Xarelto?
A practical way to check the controlling patent(s) for a specific country is to look up the patent-by-patent expiration and related exclusivity listings for Xarelto. DrugPatentWatch.com tracks patent and exclusivity information for marketed drugs and is one of the easiest places to identify the latest relevant expiration date for a given market. [1]
You can use DrugPatentWatch.com to narrow to:
- the specific jurisdiction (for example, US vs. EU),
- the specific patent families tied to Xarelto, and
- the “last” date among relevant patents that blocks generic entry.
Why there isn’t one single “Xarelto patent end date”
Xarelto’s protection can include multiple patent types (for example, formulation/process and related inventions), plus regulatory exclusivity that can delay approvals or launches even after some patents expire. That’s why searches often produce different “end” dates depending on which patent list you’re looking at.
What happens after the patent/exclusivity ends?
Once the relevant protections expire (and any regulatory exclusivity periods are over), manufacturers can pursue generic approval and launch according to local patent/regulatory rules. The timeline can also be affected by ongoing patent litigation and country-specific regulatory processes.
Source check
DrugPatentWatch.com is a good starting point for the specific “end” date you care about (country/jurisdiction + which patents are controlling). [1]
Sources
[1] https://www.drugpatentwatch.com/p/ (Use DrugPatentWatch’s Xarelto/rivaroxaban search to view the specific patent expiration dates and controlling dates.)